Abstract
Atopic dermatitis (AD) is a common, highly pruritic, and chronic, relapsing, inflammatory skin disorder. There are several modalities, which have been used in the treatment of AD, but current standard therapies have variable efficacy and potential systemic side effects. We reviewed the literature, recent patents and summarized the effective and potential effective treatment alternatives and constituted four categories and steps to achieve the best treatment modalities for each patient with AD. Supportive care, avoidance of skin irritants and allergens, topical creams, phototherapy and systemic drugs are still the best choices of treatment. Optimal effective treatment agents with low side effects are still requested.
Keywords: Atopic dermatitis, treatment, new drugs, patents
Recent Patents on Inflammation & Allergy Drug Discovery
Title: Current Concept in the Treatment of Atopic Dermatitis
Volume: 1 Issue: 2
Author(s): Murat Borlu and Ebru Guler
Affiliation:
Keywords: Atopic dermatitis, treatment, new drugs, patents
Abstract: Atopic dermatitis (AD) is a common, highly pruritic, and chronic, relapsing, inflammatory skin disorder. There are several modalities, which have been used in the treatment of AD, but current standard therapies have variable efficacy and potential systemic side effects. We reviewed the literature, recent patents and summarized the effective and potential effective treatment alternatives and constituted four categories and steps to achieve the best treatment modalities for each patient with AD. Supportive care, avoidance of skin irritants and allergens, topical creams, phototherapy and systemic drugs are still the best choices of treatment. Optimal effective treatment agents with low side effects are still requested.
Export Options
About this article
Cite this article as:
Murat Borlu and Ebru Guler , Current Concept in the Treatment of Atopic Dermatitis, Recent Patents on Inflammation & Allergy Drug Discovery 2007; 1(2) . https://dx.doi.org/10.2174/187221307780979900
DOI https://dx.doi.org/10.2174/187221307780979900 |
Print ISSN 1872-213X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-2710 |
Related Articles
-
Anti-obesity Effects of Some Plant Extracts in Rats Fed with High-Fat
Diet
The Natural Products Journal PACAP is Implicated in the Stress Axes
Current Pharmaceutical Design Complementary and Alternative Medical Therapies in Fibromyalgia
Current Pharmaceutical Design Chemistry and Biology of Thyrotropin-Releasing Hormone (TRH) and its Analogs
Current Medicinal Chemistry FoxO1 Inhibitors: The Future Medicine for Metabolic Disorders?
Current Diabetes Reviews Depression and Disturbed Bone Metabolism: A Narrative Review of the Epidemiological Findings and Postulated Mechanisms
Current Molecular Medicine Molecular Targets for Promoting Wound Healing in Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Early Prediction of Preeclampsia: Hope for Early Intervention?
Current Women`s Health Reviews Kinase CK2 Inhibition: An Update
Current Medicinal Chemistry The Implicit Power Motive and Adolescents` Salivary Cortisol Responses to Acute Psychosocial Stress and Exercise in School
CNS & Neurological Disorders - Drug Targets Exosomes and Exosomal microRNAs in Age-associated Stroke
Current Vascular Pharmacology Behavioral and Neurochemical Studies in Distinct Animal Models of Ethanols Motivational Effects
Current Drug Abuse Reviews Tryptophan Catabolites and Migraine
Current Pharmaceutical Design Leptin and Inflammation
Current Immunology Reviews (Discontinued) Reproductive Effects of Low-to-Moderate Medical Radiation Exposure
Current Medicinal Chemistry Pharmacokinetics and Systemic Activity of a New Patent of an Inhaled Corticosteroid/Long-Acting β2-Agonist Combination for Use in Asthma Therapy: Fluticasone Furoate/Vilanterol Trifenatate
Recent Patents on Inflammation & Allergy Drug Discovery Positive Social Interactions in a Lifespan Perspective with a Focus on Opioidergic and Oxytocinergic Systems: Implications for Neuroprotection
Current Neuropharmacology Collateral Damage: Contribution of Peripheral Inflammation to Neurodegenerative Diseases
Current Topics in Medicinal Chemistry Regulation of Neurogenesis and Angiogenesis in Depression
Current Neurovascular Research Multifaceted Approach to Circadian Rhythm: Redox, Oxidative Stress, Melatonin, Antioxidants, Nitric Oxide, Hypoxia, Anesthetics, Cortisol and Cocaine
Current Chemical Biology